Literature DB >> 6200335

Receptors for substance P. I. The pharmacological preparations.

D Regoli, P D'Orléans-Juste, E Escher, J Mizrahi.   

Abstract

The undecapeptide substance P (SP) is both a potent stimulant of intestinal (guinea pig ileum), vascular venous (rabbit mesenteric vein) and tracheal (guinea pig trachea) smooth muscles, and a relaxant of large arteries (dog common carotid artery, rabbit aorta). SP also decreases the peripheral vascular resistance in the coronary vessels of rabbit isolated hearts. The contractions of the guinea pig ileum in response to SP are partially antagonised by atropine and significantly depressed by indomethacin, while the contractions of the guinea pig trachea are strongly potentiated by indomethacin. Large arteries, but not the veins, are insensitive to SP when the endothelium is removed, and slightly less responsive to the peptide when this is applied in the presence of mepacrine, eicosatetraynoid acid or BW 755C. These results indicate that all myotropic actions of SP, except that on venous smooth muscle, are partially or completely indirect and most of them are due to the release of endogenous agents: these are acetylcholine, prostaglandins and possibly histamine in the guinea pig ileum, prostaglandins and possibly a leukotriene in the guinea pig trachea and a still unidentified factor of endothelial origin in dog and rabbit large arteries. The effect of substance P on the rabbit isolated anterior mesenteric vein appears to be a direct one.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6200335     DOI: 10.1016/0014-2999(84)90447-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Extracellular matrix regulates smooth muscle responses to substance P.

Authors:  C W Bowers; L M Dahm
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.

Authors:  I J Beresford; P J Birch; R M Hagan; S J Ireland
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

3.  Effects of capsaicin on vascular smooth muscle.

Authors:  S P Duckles
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-05       Impact factor: 3.000

4.  The effect of compound 48/80, substance P and pentagastrin on the isolated guinea pig atrium.

Authors:  L Stanovnik; M Logonder-Mlinsek; F Erjavec
Journal:  Agents Actions       Date:  1986-04

5.  Expression of functional neurotransmitter receptors in an uninnervated tissue: avian amnion.

Authors:  C W Bowers
Journal:  Cell Tissue Res       Date:  1989-11       Impact factor: 5.249

6.  Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B.

Authors:  O Ploux; S Lavielle; G Chassaing; S Julien; A Marquet; P d'Orléans-Juste; S Dion; D Regoli; J C Beaujouan; L Bergström
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Substance P responsiveness of smooth muscle cells is regulated by the integrin ligand, thrombospondin.

Authors:  L M Dahm; C W Bowers
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

8.  Actions of tachykinins on the rabbit mesenteric artery: substance P and [Glp6,L-Pro9]SP6-11 are potent agonists for endothelial neurokinin-1 receptors.

Authors:  A Stewart-Lee; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

9.  Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles.

Authors:  John J McGuire; Morley D Hollenberg; Patricia Andrade-Gordon; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

10.  On the nature of the contractile motor responses of the rat stomach elicited by serotonin or substance P in vitro.

Authors:  P Lidberg; A Dahlström; H Ahlman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.